JP2005538150A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005538150A5 JP2005538150A5 JP2004531341A JP2004531341A JP2005538150A5 JP 2005538150 A5 JP2005538150 A5 JP 2005538150A5 JP 2004531341 A JP2004531341 A JP 2004531341A JP 2004531341 A JP2004531341 A JP 2004531341A JP 2005538150 A5 JP2005538150 A5 JP 2005538150A5
- Authority
- JP
- Japan
- Prior art keywords
- activity
- estrogen
- dose
- phase
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940011871 estrogen Drugs 0.000 claims 98
- 239000000262 estrogen Substances 0.000 claims 98
- 239000000126 substance Substances 0.000 claims 70
- 230000001747 exhibiting effect Effects 0.000 claims 59
- 230000001076 estrogenic effect Effects 0.000 claims 45
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 42
- 230000000694 effects Effects 0.000 claims 37
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 26
- 229930182833 estradiol Natural products 0.000 claims 26
- 229960005309 estradiol Drugs 0.000 claims 26
- 239000000825 pharmaceutical preparation Substances 0.000 claims 24
- 229960001207 micronized progesterone Drugs 0.000 claims 12
- 239000000583 progesterone congener Substances 0.000 claims 12
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 claims 9
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical group OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims 9
- 229960003387 progesterone Drugs 0.000 claims 9
- 239000000186 progesterone Substances 0.000 claims 9
- 230000009469 supplementation Effects 0.000 claims 8
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 claims 6
- 150000002148 esters Chemical class 0.000 claims 6
- IMSSROKUHAOUJS-MJCUULBUSA-N mestranol Chemical compound C1C[C@]2(C)[C@@](C#C)(O)CC[C@H]2[C@@H]2CCC3=CC(OC)=CC=C3[C@H]21 IMSSROKUHAOUJS-MJCUULBUSA-N 0.000 claims 6
- JKKFKPJIXZFSSB-UHFFFAOYSA-N 1,3,5(10)-estratrien-17-one 3-sulfate Natural products OS(=O)(=O)OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 JKKFKPJIXZFSSB-UHFFFAOYSA-N 0.000 claims 5
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 claims 5
- 229960000417 norgestimate Drugs 0.000 claims 4
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 claims 3
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 3
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 claims 3
- 241000283073 Equus caballus Species 0.000 claims 3
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims 3
- IMONTRJLAWHYGT-ZCPXKWAGSA-N Norethindrone Acetate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)C)[C@@]1(C)CC2 IMONTRJLAWHYGT-ZCPXKWAGSA-N 0.000 claims 3
- ICTXHFFSOAJUMG-SLHNCBLASA-N Norethynodrel Chemical compound C1CC(=O)CC2=C1[C@H]1CC[C@](C)([C@](CC3)(O)C#C)[C@@H]3[C@@H]1CC2 ICTXHFFSOAJUMG-SLHNCBLASA-N 0.000 claims 3
- 102000001307 androgen receptors Human genes 0.000 claims 3
- 108010080146 androgen receptors Proteins 0.000 claims 3
- 229960001616 chlormadinone acetate Drugs 0.000 claims 3
- 239000000470 constituent Substances 0.000 claims 3
- 229960000978 cyproterone acetate Drugs 0.000 claims 3
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 claims 3
- 239000002552 dosage form Substances 0.000 claims 3
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 claims 3
- 229960001348 estriol Drugs 0.000 claims 3
- 229960003399 estrone Drugs 0.000 claims 3
- 150000002170 ethers Chemical class 0.000 claims 3
- 229960004400 levonorgestrel Drugs 0.000 claims 3
- 229960002985 medroxyprogesterone acetate Drugs 0.000 claims 3
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 claims 3
- 229960001390 mestranol Drugs 0.000 claims 3
- 229940053934 norethindrone Drugs 0.000 claims 3
- 229960001652 norethindrone acetate Drugs 0.000 claims 3
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 claims 3
- 229960001858 norethynodrel Drugs 0.000 claims 3
- 230000001072 progestational effect Effects 0.000 claims 3
- 102000003998 progesterone receptors Human genes 0.000 claims 3
- 108090000468 progesterone receptors Proteins 0.000 claims 3
- PWZUUYSISTUNDW-VAFBSOEGSA-N quinestrol Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@]4(O)C#C)C)CC2=CC=3OC1CCCC1 PWZUUYSISTUNDW-VAFBSOEGSA-N 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 102000034755 Sex Hormone-Binding Globulin Human genes 0.000 claims 2
- 108010089417 Sex Hormone-Binding Globulin Proteins 0.000 claims 2
- 229960004976 desogestrel Drugs 0.000 claims 2
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical group C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- JGMOKGBVKVMRFX-HQZYFCCVSA-N dydrogesterone Chemical compound C1=CC2=CC(=O)CC[C@@]2(C)[C@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 JGMOKGBVKVMRFX-HQZYFCCVSA-N 0.000 claims 2
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- 229940083546 estradiol 0.5 mg Drugs 0.000 claims 1
- HZEQBCVBILBTEP-ZFINNJDLSA-N estropipate Chemical compound C1CNCCN1.OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 HZEQBCVBILBTEP-ZFINNJDLSA-N 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- KIQQMECNKUGGKA-NMYWJIRASA-N norgestimate Chemical compound O/N=C/1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(OC(C)=O)C#C)[C@@H]4[C@@H]3CCC2=C\1 KIQQMECNKUGGKA-NMYWJIRASA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40633102P | 2002-08-28 | 2002-08-28 | |
| PCT/CA2003/001325 WO2004019954A1 (en) | 2002-08-28 | 2003-08-28 | Estrogen replacement regimen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005538150A JP2005538150A (ja) | 2005-12-15 |
| JP2005538150A5 true JP2005538150A5 (enExample) | 2006-10-12 |
Family
ID=31978284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004531341A Pending JP2005538150A (ja) | 2002-08-28 | 2003-08-28 | エストロゲン補充療法 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8946198B2 (enExample) |
| EP (1) | EP1539184B1 (enExample) |
| JP (1) | JP2005538150A (enExample) |
| KR (1) | KR20050059092A (enExample) |
| CN (1) | CN1678324A (enExample) |
| AT (1) | ATE345804T1 (enExample) |
| AU (1) | AU2003264203A1 (enExample) |
| BR (1) | BR0313921A (enExample) |
| CA (1) | CA2495330A1 (enExample) |
| CY (1) | CY1106019T1 (enExample) |
| DE (1) | DE60309895T2 (enExample) |
| DK (1) | DK1539184T3 (enExample) |
| ES (1) | ES2277139T3 (enExample) |
| HR (1) | HRP20050291A2 (enExample) |
| IL (1) | IL166585A0 (enExample) |
| MX (1) | MXPA05002294A (enExample) |
| NO (1) | NO20051545L (enExample) |
| NZ (1) | NZ538342A (enExample) |
| PL (1) | PL374762A1 (enExample) |
| PT (1) | PT1539184E (enExample) |
| RS (1) | RS20050184A (enExample) |
| RU (1) | RU2340345C2 (enExample) |
| UA (1) | UA82851C2 (enExample) |
| WO (1) | WO2004019954A1 (enExample) |
| ZA (1) | ZA200501274B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
| DE102009007771B4 (de) | 2009-02-05 | 2012-02-16 | Bayer Schering Pharma Aktiengesellschaft | Bukkales Applikationssystem, 17α-Estradiol enthaltend |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| CA2856520C (en) | 2011-11-23 | 2021-04-06 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| MX2016011801A (es) * | 2014-03-12 | 2017-07-14 | Warner Chilcott Co Llc | Crema de estradiol de dosis baja. |
| AR100562A1 (es) | 2014-05-22 | 2016-10-12 | Therapeuticsmd Inc | Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal |
| MY195019A (en) | 2015-06-18 | 2023-01-03 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| HUE054589T2 (hu) | 2015-06-18 | 2021-09-28 | Estetra Sprl | Szájban diszpergálódó esztetrol tartalmú tabletta |
| JP6866560B2 (ja) | 2015-06-18 | 2021-04-28 | エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ | エステトロール成分を含有する口腔内崩壊性投与単位 |
| MD3310346T2 (ro) | 2015-06-18 | 2021-06-30 | Estetra Sprl | Comprimată orodispersabilă ce conține estetrol |
| WO2016210003A2 (en) | 2015-06-22 | 2016-12-29 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| AU2017239645A1 (en) | 2016-04-01 | 2018-10-18 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| KR102712911B1 (ko) | 2016-08-05 | 2024-10-04 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| ES2054784T3 (es) * | 1987-08-08 | 1994-08-16 | Akzo Nv | Un metodo para la fabricacion de un implante. |
| US4900734A (en) * | 1987-08-27 | 1990-02-13 | Maxson Wayne S | Novel pharmaceutical composition containing estradiol and progesterone for oral administration |
| US5276022A (en) * | 1987-09-24 | 1994-01-04 | Jencap Research Ltd. | Hormone preparation and method |
| AU630334B2 (en) * | 1987-09-24 | 1992-10-29 | Jencap Research Ltd. | Hormone preparations for hormone replacement therapy and contraceptive method |
| US5256421A (en) * | 1987-09-24 | 1993-10-26 | Jencap Research Ltd. | Hormone preparation and method |
| US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| US5422119A (en) * | 1987-09-24 | 1995-06-06 | Jencap Research Ltd. | Transdermal hormone replacement therapy |
| US5382873A (en) * | 1991-12-04 | 1995-01-17 | U.S. Philips Corporation | High-pressure discharge lamp with incandescing metal droplets |
| US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
| DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
| DK0836506T4 (da) * | 1995-06-07 | 2012-01-30 | Ortho Mcneil Pharm Inc | Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen |
| US6506390B2 (en) * | 1996-06-25 | 2003-01-14 | Akzo Nobel | Progestogen-anti-progestogen regimens |
| CA2267743C (en) * | 1999-03-30 | 2011-07-26 | Robert F. Casper | Low dose estrogen interrupted hormone replacement therapy |
| US6653298B2 (en) * | 2000-01-14 | 2003-11-25 | Sterix Limited | Composition |
| DE10100911A1 (de) * | 2001-01-11 | 2002-08-01 | Schering Ag | Verfahren zur Hormonersatztherapie und dessen Darreichungsform |
-
2003
- 2003-08-28 RS YUP-2005/0184A patent/RS20050184A/sr unknown
- 2003-08-28 WO PCT/CA2003/001325 patent/WO2004019954A1/en not_active Ceased
- 2003-08-28 JP JP2004531341A patent/JP2005538150A/ja active Pending
- 2003-08-28 CN CNA038205157A patent/CN1678324A/zh active Pending
- 2003-08-28 EP EP03790602A patent/EP1539184B1/en not_active Expired - Lifetime
- 2003-08-28 ES ES03790602T patent/ES2277139T3/es not_active Expired - Lifetime
- 2003-08-28 HR HR20050291A patent/HRP20050291A2/xx not_active Application Discontinuation
- 2003-08-28 MX MXPA05002294A patent/MXPA05002294A/es active IP Right Grant
- 2003-08-28 RU RU2005108977/15A patent/RU2340345C2/ru not_active IP Right Cessation
- 2003-08-28 BR BR0313921-2A patent/BR0313921A/pt not_active IP Right Cessation
- 2003-08-28 US US10/526,064 patent/US8946198B2/en active Active
- 2003-08-28 PL PL03374762A patent/PL374762A1/xx not_active Application Discontinuation
- 2003-08-28 KR KR1020057003209A patent/KR20050059092A/ko not_active Withdrawn
- 2003-08-28 AU AU2003264203A patent/AU2003264203A1/en not_active Abandoned
- 2003-08-28 NZ NZ538342A patent/NZ538342A/en unknown
- 2003-08-28 IL IL16658503A patent/IL166585A0/xx unknown
- 2003-08-28 CA CA002495330A patent/CA2495330A1/en not_active Abandoned
- 2003-08-28 PT PT03790602T patent/PT1539184E/pt unknown
- 2003-08-28 AT AT03790602T patent/ATE345804T1/de not_active IP Right Cessation
- 2003-08-28 DK DK03790602T patent/DK1539184T3/da active
- 2003-08-28 DE DE60309895T patent/DE60309895T2/de not_active Expired - Lifetime
- 2003-08-28 UA UAA200502488A patent/UA82851C2/uk unknown
-
2005
- 2005-02-11 ZA ZA200501274A patent/ZA200501274B/en unknown
- 2005-03-23 NO NO20051545A patent/NO20051545L/no not_active Application Discontinuation
-
2007
- 2007-02-14 CY CY20071100200T patent/CY1106019T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005538150A5 (enExample) | ||
| RU2005108977A (ru) | Схема восполнения эстрогена | |
| CA2267743A1 (en) | Low dose estrogen interrupted hormone replacement therapy | |
| KR960001371B1 (ko) | 폐경기 전의 여성용 혼합 제형 및 이를 포함하는 팩 | |
| AU2021262853B2 (en) | Contraceptive compositions and methods for improved efficacy and modulation of side effects | |
| JPH04290830A (ja) | 避妊薬処方物 | |
| JP2010508275A5 (enExample) | ||
| JP2010248270A (ja) | 避妊用の組成 | |
| PT99782A (pt) | Processo de fabrico de contraceptivos orais de baixo teor em estrogenio | |
| JP2004508398A5 (enExample) | ||
| RU2001117204A (ru) | Трехфазный пероральный контрацептив | |
| RU2009120528A (ru) | Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла | |
| RU96119957A (ru) | Фармацевтический комбинированный препарат для гормональной контрацепции | |
| KR970704450A (ko) | 자궁내막증식증 또는 자궁평활근종을 치료하기 위한 프로게스테론 길항제 및 게스타겐의 용도(Use of a Progesterone Antagonist and of a Gestagen for the Treatment of Endometriosis or Leiomyomate Uteri) | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| JP2008540482A5 (enExample) | ||
| WO2002094281A1 (en) | Means and method for hormonal contraception | |
| JP2942560B2 (ja) | エストロゲン欠乏症治療用組成物 | |
| US7569560B2 (en) | Extended cycle multiphasic oral contraceptive method | |
| JP2005530791A (ja) | 結合型エストロゲンとトリメゲストンの組み合わせを用いたホルモン補充療法 | |
| TW200534860A (en) | Multiphase product for contraception based on a natural oestrogen | |
| JP2003535127A (ja) | 低用量経口避妊薬用のスターターキット | |
| CA2248841C (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
| EP1462107A1 (en) | Method of female contraception and kit for use in such method | |
| US20080280861A1 (en) | Method of Female Contraception and a Kit For Use Therein |